Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ARPO

Aerpio Pharmaceuticals (ARPO)

Aerpio Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARPO
DateTimeSourceHeadlineSymbolCompany
21/06/202320:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202320:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202320:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202320:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202320:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
21/06/202320:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
17/06/202305:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
06/06/202309:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
06/05/202306:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/05/202308:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/04/202303:25Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/04/202302:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/04/202302:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
06/04/202309:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
05/04/202306:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
30/03/202307:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
30/03/202307:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
30/03/202307:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202321:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
29/03/202307:08Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/03/202323:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
04/03/202300:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
03/03/202308:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
14/02/202322:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
11/02/202305:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARPOAerpio Pharmaceuticals Inc
05/01/202308:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
28/11/202222:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
10/11/202208:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARPOAerpio Pharmaceuticals Inc
10/11/202200:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
07/11/202222:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ARPOAerpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARPO